Venue: The Hub Cira Centre
|Event Date/Time: May 09, 2012||End Date/Time: May 10, 2012|
* Instant market access to a growing local market;
* Lower operational costs;
* Access to new technology and its educated workforce,
* The Chinese government's financial commitment to the healthcare industry.
When it comes to outsourcing drug discovery, Partnership and Licensing (P&L) savvy is critical to working with this increasingly dynamic Chinese market. Besides, why just limit your partnership to R&D?
That's why this year's U.S.-CHINA PHARMA conference has been expanded to cover two very important topics: Outsourcing Drug Discovery in China (May 9th); and Partnership and Licensing Tactics (May 10th).
So take advantage of this extended opportunity. Join the U.S.-CHINA PHARMA conference on May 9-10 in Philadelphia to learn about best practices and strategies to manage an outsourced drug discovery program in China. Here you'll find hundreds of innovative clinical partners and sponsors who are working on China projects, and have the opportunities to source complete integrated services. Join us today and walk away with partners for your next projects.